Levetiracetam Clonmel (Levetiracetam)

• Levetiracetam is an antiepileptic drug that reduces neuronal excitability in various seizure types.
• Partial seizures: helps achieve seizure control in focal onset epilepsy.
• Generalized tonic‑clonic seizures: reduces frequency of bilateral convulsive episodes.
• Myoclonic seizures: decreases sudden muscle jerks associated with juvenile myoclonic epilepsy.

• Levetiracetam binds selectively to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal firing. This interaction reduces excessive synaptic transmission, thereby lowering the likelihood of seizure propagation across neural networks. The exact downstream effects are not fully understood, but SV2A modulation is considered central to its antiepileptic activity.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Fatigue: generalized tiredness or lack of energy.
• Headache: mild to moderate cranial pain.
• Irritability: mood changes or increased agitation.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Mood or behavior changes: depression, suicidal thoughts, or aggressive behavior.
• Hematologic abnormalities: low blood cell counts such as leukopenia or thrombocytopenia.

When prescribing Levetiracetam, clinicians should consider several safety measures to minimize risks.

• Renal function: adjust dose in patients with impaired clearance.
• Psychiatric history: monitor for mood swings or suicidal ideation.
• Pregnancy: evaluate risk‑benefit as safety data are limited.
• Concomitant CNS depressants: use caution as additive sedation may occur.
• Driving and operating machinery: advise patients to assess personal response before engaging in hazardous activities.
• Store at ambient temperature: keep below 25 °C, in original container, protected from moisture and light.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

• Carbamazepine: may reduce levetiracetam plasma levels, decreasing seizure control.
• Phenobarbital: can lower levetiracetam concentrations, potentially compromising effectiveness.

Moderate Interactions (Monitor Closely)

• Alcohol: combined use may enhance central nervous system depression.
• Opioids: may increase risk of respiratory depression when used together.
• Other antiepileptic drugs (e.g., valproate): may require dose adjustments based on therapeutic monitoring.